FARXIGA 10 mg as monotherapy also provided statistically significant improvements in FPG and statistically significant reduction in body weight compared with metformin alone and was non inferior to metformin XR monotherapy in lowering HbA1c Figure 2: Adjusted Mean Change from Baseline Over Time in HbA1c (%) in a 24-Week Active-Controlled Trial of FARXIGA Initial Combination Therapy with Metformin XR In a second trial (NCT00643851), 603 patients were randomized to 1 of 3 treatment arms following a 1-week lead-in period: FARXIGA 5 mg plus metformin XR (up to 2,000 mg per day), FARXIGA 5 mg plus placebo, or metformin XR (up to 2,000 mg per day) plus placebo
The role of dopamine in the pathophysiology of depression
This targeted distribution contributes to the favorable side effect profile relative to systemic weight loss interventions like stimulants
Recalls & Warnings May 03, 2013 Maker of Probiotic, Iron and Folic Acid Supplements Warned For Manufacturing Violations On April 17, 2013, the FDA issued a warning letter to Hillestad Pharmaceuticals USA, Inc
Birth defects occur in 3-4% of pregnancies among women with these conditions versus 2-3% in the general population
